Multivariate analysis of factors affecting the immunogenicity of trivalent inactivated influenza vaccine in school-age children

被引:4
|
作者
Freeman, G. [1 ]
Ng, S. [2 ]
Perera, R. A. P. M. [3 ,4 ]
Fang, V. J. [1 ]
Ip, D. K. M. [1 ]
Leung, G. M. [5 ]
Peiris, J. S. M. [3 ,4 ]
Cowling, B. J. [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Div Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China
[2] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA
[3] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Div Publ Hlth Lab Sci, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Influenza Res, Hong Kong, Hong Kong, Peoples R China
[5] Univ Hong Kong, Li Ka Shing Fac Med, Div Community Med & Publ Hlth Practice, Hong Kong, Hong Kong, Peoples R China
来源
EPIDEMIOLOGY AND INFECTION | 2015年 / 143卷 / 03期
关键词
Immunization (vaccination); influenza; serology; statistics; PROTECTIVE EFFICACY; PANDEMIC INFLUENZA; ANTIBODY-RESPONSE; IMMUNE-RESPONSES;
D O I
10.1017/S0950268814000855
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We examined factors affecting the immunogenicity of trivalent inactivated influenza vaccination (TIV) in children using the antibody titres of children participating in a Hong Kong community-based study. Antibody titres of strains included in the 2009-2010 northern hemisphere TIV [seasonal A(H1N1), seasonal A(H3N2) and B (Victoria lineage)] and those not included in the TIV [2009 pandemic A(H1N1) and B (Yamagata lineage)] were measured by haemagglutination inhibition immediately before and 1 month after vaccination. Multivariate regression models were fitted in a Bayesian framework to characterize the distribution of changes in antibody titres following vaccination. Statistically significant rises in geometric mean antibody titres were observed against all strains, with a wide variety of standard deviations and correlations in rises observed, with the influenza type B antibodies showing more variability than the type A antibodies. The dynamics of antibody titres after vaccination can be used in more complex models of antibody dynamics in populations.
引用
收藏
页码:540 / 549
页数:10
相关论文
共 50 条
  • [1] Immunogenicity and safety of a trivalent inactivated influenza vaccine
    Fadlyana, Eddy
    Rusmili, Kusnandi
    Bachtiar, Novilia Sjafri
    Gunadi, Rachmat
    Sukandar, Hadyana
    PAEDIATRICA INDONESIANA, 2011, 51 (01) : 22 - 28
  • [2] Safety and immunogenicity of trivalent inactivated influenza vaccine in infants
    Halasa, Natasha B.
    Gerber, Michael A.
    Chen, Qingxia
    Wright, Peter F.
    Edwards, Kathryn M.
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (10): : 1448 - 1454
  • [3] Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children
    Esposito, Susanna
    Giavoli, Claudia
    Trombetta, Claudia
    Bianchini, Sonia
    Montinaro, Valentina
    Spada, Anna
    Montomoli, Emanuele
    Principi, Nicola
    VACCINE, 2016, 34 (01) : 56 - 60
  • [4] Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine
    Talbot, H. Keipp
    Keitel, Wendy
    Cate, Thomas R.
    Treanor, John
    Campbell, James
    Bradye, Rebecca C.
    Graham, Irene
    Dekker, Cornelia L.
    Ho, Dora
    Winokur, Patricia
    Walter, Emmanuel
    Bennet, Jillian
    Formica, Neil
    Hartel, Gunter
    Skeljo, Maryanne
    Edwards, Kathryn M.
    VACCINE, 2008, 26 (32) : 4057 - 4061
  • [5] Immunogenicity of the Trivalent Inactivated Influenza Vaccine in Young Children Less than 4 Years of Age, with a Focus on Age and Baseline Antibodies
    Mugitani, Ayumi
    Ito, Kazuya
    Irie, Shin
    Eto, Takashi
    Ishibashi, Motoki
    Ohfuji, Satoko
    Fukushima, Wakaba
    Maeda, Akiko
    Hirota, Yoshio
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (09) : 1253 - 1260
  • [6] Immunogenicity and Safety of an Inactivated Trivalent Split Influenza Virus Vaccine in Young Children with Recurrent Wheezing
    Bae, E. Young
    Choi, Ui Yoon
    Kwon, Hyo Jin
    Jeong, Dae Chul
    Rhim, Jung Woo
    Ma, Sang Hyuk
    Lee, Kyung Il
    Kang, Jin Han
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (06) : 811 - 817
  • [7] Impact of vitamin D administration on immunogenicity of trivalent inactivated influenza vaccine in previously unvaccinated children
    Principi, Nicola
    Marchisio, Paola
    Terranova, Leonardo
    Zampiero, Alberto
    Baggi, Elena
    Daleno, Cristina
    Tirelli, Silvia
    Pelucchi, Claudio
    Esposito, Susanna
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (05) : 969 - 974
  • [8] Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer
    Kotecha, Rishi S.
    Wadia, Ushma D.
    Jacoby, Peter
    Ryan, Anne L.
    Blyth, Christopher C.
    Keil, Anthony D.
    Gottardo, Nicholas G.
    Cole, Catherine H.
    Barr, Ian G.
    Richmond, Peter C.
    CANCER MEDICINE, 2016, 5 (02): : 285 - 293
  • [9] Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults
    Greenberg, David P.
    Robertson, Corwin A.
    Noss, Michael J.
    Blatter, Mark M.
    Biedenbender, Rex
    Decker, Michael D.
    VACCINE, 2013, 31 (05) : 770 - 776
  • [10] Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
    Mo, Zhaojun
    Nong, Yi
    Liu, Shuzhen
    Shao, Ming
    Liao, Xueyan
    Go, Kerry
    Lavis, Nathalie
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (06) : 1272 - 1278